Publication | Closed Access
Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study
13
Citations
10
References
2005
Year
Weekly paclitaxel could be safely administered and achieved a relatively high response rate. Weekly paclitaxel would be a good candidate second-line therapy for recurrent or advanced breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1